BioCentury
ARTICLE | Top Story

Takeda announces global reorganization

September 17, 2014 2:04 AM UTC

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) announced the reorganization of its commercial and R&D operations -- its first major organizational move since naming Christophe Weber as COO effective April 2014 and president effective June 2014.

Takeda said the reorganization is designed to strengthen communication between its commercial and R&D divisions. ...